Preview

User

Not a user? Register with this site Forgot your password?

Neurology, Neuropsychiatry, Psychosomatics

Advanced search
Fullscreen

For citations:

Boyko AN, Simaniv TO, Prokopyeva TA, Petrov SV, Melnikov MV. Switching from ocrelizumab to ofatumumab: key potential reasons based on real-world clinical practice. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2025;17(3):92-97. (In Russ.) https://doi.org/10.14412/2074-2711-2025-3-92-97



Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)

"IMA-PRESS" LLC 
115093, Russian Federation, Moscow,
Partijnyj per, 1, bld. 58, of. 745
E-mail: info@ima-press.net
Phone: +7(495) 926-7814

Processing of personal data
supported by NEICON (Elpub lab)